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Abstract In addition to mediating the classical transcriptional
effects of estrogen, estrogen receptors (ERs) are now known to
regulate gene expression in the absence of estrogen by ligand-
independent activation pathways, and to mediate the rapid, non-
genomic effects of estrogen as well. ERs have been shown to
associate with the cell membrane, and recent studies demonstrate
that this subpopulation of membrane-associated ER mediates the
rapid effects of estrogen. To date, however, little is known
regarding the pathways that regulate the distribution of the ER
between the nuclear and membrane fractions. In the current
study, we demonstrate membrane localization of transiently
transfected ERK in human vascular smooth muscle cells, and
translocation of ERK from the membrane to the nucleus in
response to both estrogen-dependent and estrogen-independent
stimulation. Mutational analyses identified serine 118 as the
critical residue regulating nuclear localization following estro-
gen-independent stimulation, but not following estrogen stimula-
tion. Induction of nuclear localization of ERK by estrogen-
independent, but not estrogen-dependent stimulation was blocked
by both pharmacologic and genetic inhibition of mitogen-
activated protein (MAP) kinase activation. Furthermore, con-
stitutive activation of MAP kinase resulted in nuclear transloca-
tion of ERK. These overexpression studies support that MAP
kinase-mediated phosphorylation of ERK induces nuclear
localization of the ER in response to estrogen-independent, but
not estrogen-dependent stimulation, demonstrating stimulus-
specific molecular pathways regulate the nuclear localization of
the ER. These findings identify a previously unrecognized
pathway that regulates the intracellular localization of the ER,
and represent the first demonstration that the distribution of the
ER between membrane and nuclear compartments is regulated
by physiologic stimuli. ß 2002 Federation of European Bio-
chemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
The diverse biological e¡ects of estrogen are mediated by
estrogen receptors (ERs) of which two are known, ERK and
ERL [1^4]. Classically, ERs function as ligand-activated tran-
scription factors [5,6] and as such are considered to be con-
¢ned to the nucleus where they regulate gene transcription in
response to hormone binding. Recent reports, however, have
de¢ned two additional molecular pathways for ERK-mediated
e¡ects in cells (reviewed in [7^9]). First, ERK can be transcrip-
tionally activated in the absence of estrogen, a process re-
ferred to as ligand-independent activation (reviewed in [8]).
Ligand-independent activation of ERK has been reported in
response to a variety of stimuli (e.g. serum [10], dopamine
[11], cAMP [12], caveolin-1 [13], Akt kinase [14], epidermal
growth factor (EGF) [15] and speci¢c cyclins [16^18]). The
most completely studied pathway for ligand-independent
ERK activation involves mitogen-activated protein (MAP)
kinase-mediated activation of ERK in tumor-derived cell
lines [15,19,20]. In Cos1 cells, for example, growth factor-in-
duced activation of ERK results from MAP kinase-mediated
phosphorylation of serine 118 in the A/B domain of the ER
[15].
The second recently described alternative mechanism for
ERK-mediated signaling in cells involves rapid e¡ects of estro-
gen (reviewed in [7,9]). The rapid e¡ects of estrogen occur
within 5^15 min of estrogen exposure without alterations in
gene expression. Given the importance of estrogen’s e¡ects on
the cardiovascular system, non-genomic e¡ects of estrogen
have recently been examined in vascular endothelial cells. In
these cells, short-term stimulation with 17L-estradiol (E2) re-
sults in activation of both MAP kinase and Akt kinase, with
subsequent activation of endothelial cell nitric oxide synthase
[21^25]. Despite its rapid, non-genomic nature, estrogen-in-
duced nitric oxide release from endothelial cells is mediated
by ERK [24^26]. Rapid e¡ects of estrogen have also been
reported in vascular smooth muscle cells (VSMC) [27], though
the mechanisms that mediate these e¡ects are less well under-
stood. In vivo studies demonstrating that administration of
estrogen acutely enhances vasodilation in both animal and
human subjects supports a physiologically relevant role for
non-genomic activation of the ER [22,28^31].
Recent studies exploring further the non-genomic activation
of ERK in endothelial cells have shown that ERK, localized to
caveolae associated with the cell surface membrane, is capable
of mediating E2-induced nitric oxide release [23]. Rapid, es-
trogen-mediated activation of several signaling pathways has
also been reported recently in CHO cells, and in these ERK
overexpression studies, ERK was also detected in cell mem-
branes [32]. These studies con¢rmed previous reports [33^
35,40] suggesting that though the majority of ER protein is
found within the nucleus, a subpopulation of ERK can also be
detected in the cell membrane.
Taken together, these studies suggest that ERs are not con-
stitutively con¢ned to the nucleus, as is widely believed, but
rather support that the receptor is present in the cell in at least
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two populations: (i) a cell membrane population that medi-
ates the rapid, non-genomic e¡ects of estrogen; and (ii) a
nuclear population that mediates changes in gene transcrip-
tion. We hypothesized that the distribution of the ER between
the membrane and nuclear compartments is regulated by
physiologic stimuli and thus undertook the current series of
experiments to investigate the molecular pathways that regu-
late the intracellular localization of ERK. The results pre-
sented below demonstrate that hormone-dependent and hor-
mone-independent stimuli lead to nuclear localization of ERK
via distinct molecular pathways.
2. Materials and methods
Unless otherwise speci¢ed, all chemicals were from Sigma Chemical
Co. (St. Louis, MO, USA).
2.1. Cell culture techniques
Human VSMC were obtained by standard explant techniques as
described [36]. Rad91 cells are a spontaneously immortalized VSMC
line derived from a human radial artery. Cells were grown in phenol
red-free Dulbecco’s modi¢ed Eagle’s medium with 10% estrogen-de¢-
cient fetal bovine serum (ED-FBS) as described [36]. VSMC were used
at passages 4^6 and Rad91 cells were used at passages 6^18. GH3B6
cells (rat pituitary tumor cells; kind gift of Cheryl Watson) [35] were
grown in F-10 with 2.5% calf serum and 12.5% horse serum.
2.2. Plasmids
pCMV3ERK, an expression plasmid for full-length, wild-type hu-
man ERK, was constructed by cloning the ERK cDNA into the
pCDNA3.1 vector as described [10]. The plasmid pCMV3ER-NTF
was produced by inserting the coding sequence for an eight-amino
acid epitope tag recognized by a commercially available monoclonal
antibody (M2) at the 5P end of the ERK coding sequence in
pCMV3ER as described [10]. To facilitate studies of the subcellular
distribution of ERK, we next constructed an expression plasmid for an
N-terminal chimeric green £uorescent protein (GFP)-human ERK
protein in the backbone vector pEGFP. The transcriptional integrity
of the chimeric protein was studied extensively in preliminary experi-
ments using an estrogen response element reporter plasmid [36], and
the chimeric GFP-ERK behaved identically in all instances to the
wild-type ERK (data not shown), con¢rming previous reports with a
similar construct [37]. The plasmid pCMV3ER-S118A which contains
an alanine for serine substitution at amino acid 118 was constructed
by the Kunkle method as described [10]. The plasmid pCMV3ER-
S118E was constructed using the QuikChange1 site-directed muta-
genesis kit (Stratagene, La Jolla, CA, USA), according to the manu-
facturer’s instructions. The cDNA inserts of all plasmids with mutant
ER constructs were sequenced in their entirety to ensure that no
inadvertent mutations were introduced during the mutagenesis or
cloning procedures. The plasmid pCMV3ER-vAB, which expresses
a truncation mutation of ERK lacking the N-terminal transcription
activation domain, and the plasmids pGST-ERK and pGST-ERL
which express GST-ER fusion proteins were the kind gift of Myles
Brown [38]. The plasmids pLNX-MAPKK and pLNX-DN-MAPKK
which express full-length wild-type and dominant negative MAP ki-
nase were the kind gift of Yukiko Gutah.
2.3. Transient transfections
Forty-eight hours prior to each experiment, cells were arrested by
serum starvation and then transfected by electroporation as described
previously [36]. Cells were plated on coverslips in 12 well plates at
approximately 80% con£uence and allowed 6 h for attachment. The
cells were rinsed and then maintained for 24 h in serum-free medium
(SFM), in the presence or absence of 1038 M E2, 1037 M ICI 182780
(a pure ER antagonist; ICI), EGF (100 ng/ml), 10% ED-FBS,
or charcoal-stripped 10% FBS (charcoal-stripped to remove any re-
sidual E2, as described [10]; S-FBS). In some experiments, the cells
were also grown in the presence or absence of the MEK1 inhibitor
PD98059 (60 WM) as described [10]. We have previously shown that
this concentration completely inhibits MAP kinase activation in
VSMC [10].
2.4. Immunostaining
Twenty-four hours after stimulation as described above, the cells
were ¢xed in 3.7% paraformaldehyde for 10 min, permeabilized with
0.3% Triton X-100, and stained with primary antibody (M2 1:1000
(Sigma); AER 320 1:100 (Neo Markers, Fremont, CA, USA); AER
304 1:100 (Neo Markers)) for 1 h at 25‡C, rinsed and then incubated
with either an FITC- or Cy3-labeled secondary antibody. Cells were
DAPI-stained (0.1 Wg/ml for 15 min at 25‡C), and then examined by
£uorescence microscopy. For experiments in which expression of en-
dogenously expressed ER was examined, the speci¢city of the staining
was investigated by pre-absorbing the antibody with either GST-ERK
or GST-ERL protein. GST fusion proteins were incubated with the
appropriate antibody, Sepharose beads were added and the mixture
was centrifuged at 14 000Ug for 20 min at 4‡C. The supernatants
were then used for immunostaining. In additional subsets of immu-
nostaining experiments, the cells were (a) not permeabilized with any
detergent prior to staining to prevent entry of the antibody into the
cell’s interior; or (b) pre-treated with trypsin for 2 min at 25‡C to
remove extracellular epitopes.
2.5. Cell counting
For each coverslip, 50 cells were counted and ERK distribution for
each cell (detected either by GFP or immunostaining) was categorized
as nuclear staining only, mild extra-nuclear staining (1+), moderate
extra-nuclear staining (2+) or predominantly extra-nuclear staining
(3+). The reader was blinded to cell treatments during all counting
procedures. For each experiment coverslips were counted in duplicate
and each experiment was independently repeated three times or more.
2.6. Immunoblotting
Cells were grown, transfected, plated in 100 mm dishes at approx-
imately 80% con£uence, and treated as described above. After an
overnight incubation, the cells were rinsed three times with ice-cold
phosphate-bu¡ered saline, and then scraped from the dish in TLB
lysis bu¡er (20 mM Tris (pH 7.5), 0.14 M NaCl, 2 mM EDTA, 1%
Triton X-100, 25 Wm L-glycerol phosphate, and 10% glycerol). The
crude lysates were centrifuged at 3000Ug for 10 min at 4‡C and the
nuclear pellet was recovered. The supernatant from this ¢rst spin was
next centrifuged at 100 000Ug for 1 h at 4‡C and the cell membrane
pellet was recovered. The remaining supernatant after the high-speed
spin contained the cytosolic fraction. The fractionated pellets were
resuspended in TLB and protein concentration was determined using
the Micro BCA Protein Assay according to the manufacturer’s in-
structions (Pierce, Rockford, IL, USA). Equal quantities of protein
from the nuclear pellet, the membrane pellet and the soluble fraction
were separated by SDS^PAGE, transferred to nitrocellulose and im-
munoblotted for ERK using either the M2 antibody (1:1000 dilution)
or AER 320 (1:200 dilution). Prior to initiation of these studies, ex-
tensive pilot studies were undertaken to exclude the possibility that
the cell membrane fraction was contaminated by nuclear proteins.
Thus, the fractionated lysates were immunoblotted for nuclear pro-
teins with an anti-Ku86 antigen antibody (1:500 dilution, Sigma). The
presence of cell membrane proteins in the membrane fraction was
con¢rmed by immunoblotting for the EGF receptor (1:500 dilution,
Upstate Biotechnology, Lake Placid, NY, USA). To ensure that the
determination of total protein concentration resulted in equal loading
of fractionated proteins on the gel, each membrane was probed with
these fraction-speci¢c antibodies and analyzed by densitometry. This
then allowed for at least semi-quantitative determination of the rela-
tive abundance of ER in each fraction.
2.7. Statistical analysis
All data are presented as mean þ S.E.M. Two-way comparisons
were made with the Student’s t-test; multiple group comparison
were made by one-way analysis of variance followed by a postdoc-
toral Student^Neuman^Keuls test. A value of P90.05 was considered
statistically signi¢cant.
3. Results
3.1. Cell surface ERs in human VSMC
Quiescent Rad91 cells, transfected with pCMV3ERK and
maintained in SFM were immunostained for ERK. A subpop-
ulation of cells exhibited signi¢cant extra-nuclear staining
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(Fig. 1A). The speci¢city of the immunodetection of ERK was
supported by control experiments demonstrating lack of stain-
ing in cells transfected only with an empty vector plasmid, and
also by abolishment of the immunostaining by pre-absorption
of the antibody with GST-ERK, but not with GST-ERL fu-
sion proteins (data not shown). To facilitate examination of
the intracellular distribution of the ER, a GFP-ERK expres-
sion plasmid was constructed and a series of studies were
undertaken to con¢rm that the subcellular distribution of
the chimeric GFP-ERK was identical to that of the wild-
type ER. For these studies, the GFP-ERK protein was visu-
alized by detecting the GFP signal and by staining with each
of two di¡erent ERK-speci¢c antibodies (AER 304 and AER
320 which recognize the N-terminal and C-terminal domains
of ERK respectively). Preliminary studies established that the
subcellular distribution of GFP-ERK did not di¡er from that
of the wild-type protein (data not shown). Furthermore, the
transcriptional competence of the GFP-ERK construct was
con¢rmed using transient transfection assays with an estrogen
response element reporter plasmid as described [10,36] (data
not shown). To determine whether the extra-nuclear ER ob-
served above represented cell surface ER, two approaches
were taken. First, unstimulated Rad91 cells transfected with
GFP-ERK were permeabilized with Triton, or left with their
membranes intact, followed by immunostaining with AER
320. In unpermeabilized cells, only extra-nuclear ER was de-
tected (Fig. 1B). In these same cells, however, the presence of
nuclear ERK was con¢rmed by the detection of GFP in the
nucleus (Fig. 1C). Lack of immunodetection of nuclear ER in
the unpermeabilized cells supports the hypothesis that the cell
membrane-associated ER is exposed to the extracellular space
since the antibody was not able to enter the cell’s interior. As
a second step to investigate the presence of cell surface ER,
unstimulated Rad91 cells were immunostained with or with-
out gentle pre-treatment with trypsin to cleave o¡ extracellu-
lar epitopes. In the absence of trypsin both extra-nuclear and
nuclear ERK was detected (Fig. 1D), whereas only nuclear
ERK was detected following trypsin treatment (Fig. 1E). As
shown in Fig. 1F immunostaining of GH3B6 cells using ERK-
speci¢c antibody con¢rmed the presence of extra-nuclear
ERK, as has previously been reported [32^35]
The presence of cell membrane ER was next examined by
Western blotting of subcellular fractions produced by di¡er-
ential centrifugation. In untransfected cells, no ER was de-
tected in the cell membrane fraction (Fig. 2A). In contrast,
ER was readily detected in the cell membrane fraction of un-
stimulated Rad91 cells transfected with ER, and this was in-
tensi¢ed by treatment with the ER antagonist ICI 182781
(Fig. 2A). Membrane ER was also detected by immunoblot-
ting with two additional ERK-speci¢c antibodies (Fig. 2B).
The membrane fraction was con¢rmed as such by staining
for EGF receptor protein (Fig. 2C), and lack of contamina-
tion of the membrane fraction with nuclear proteins was dem-
onstrated by the absence of detection in the cell membrane
fraction of the nuclear protein Ku86 (Fig. 2D). Taken togeth-
er, these data demonstrate that a subpopulation of ERK in
human VSMC is membrane-associated.
3.2. Physiologic stimuli regulate the intracellular localization of
the ER
Quanti¢cation of the proportion of VSMC expressing cell
surface ER, and the e¡ects of various physiologic stimuli on
Fig. 1. Immunocytochemical detection of cell surface ERs. Quiescent, human radial artery VSMC (Rad91 cells) were transfected with either
GFP-ERK or ERK and ER localization was visualized by £uorescent microscopy. A: GFP-ERK is distributed in both nuclear as well as extra-
nuclear compartments. B: Immunostaining of non-permeabilized Rad91 cells for ERK demonstrates only extra-nuclear staining (red). C: Visual-
ization of the ER by the GFP signal (green) demonstrates the presence of ER in the nucleus of the same cell as shown in B which was not ac-
cessible to the anti-ER antibody. D: Extra-nuclear ER immunostaining is also detected in cells in the absence of pre-treatment with trypsin. E:
Following pre-treatment with trypsin, extra-nuclear ER is no longer detectable. F: Endogenously expressed extracellular ER is also detected by
immunostaining in non-permeabilized GH3B6 cells (DAPI-stained nucleus shown in blue).
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the distribution of ER were examined next. Representative
cells are shown in Fig. 3, and summary data are shown in
Fig. 4. Quiescent Rad91 cells in SFM consisted of a mixed
population of cells expressing varying degrees of both nuclear
and extra-nuclear ER (Fig. 3A). E2 stimulation for 24 h re-
sulted in nuclear localization of ERK in most cells, and E2-
induced nuclear translocation was blocked by co-incubation
with ICI (Fig. 3B,C). Ligand-independent activators of ERK,
ED-FBS, S-FBS, or EGF also resulted in nuclear transloca-
tion of the ER, that was also blocked by ICI (Fig. 3D,F). The
Rad91 cells used in the above experiments are a spontane-
ously immortalized smooth muscle cell line, and so next we
sought to con¢rm these results in non-immortalized cells de-
rived from human saphenous veins. Nuclear localization by
estrogen-independent activators, and blockade of this by ICI,
was observed in human saphenous vein-derived VSMC as it
was in the Rad91 cells (Fig. 3G^I). Taken together, these
experiments support that membrane-associated ER in human
VSMC translocates to the nucleus following either hormone-
dependent or hormone-independent stimulation and that this
can be inhibited by ICI.
3.3. Distinct pathways mediate nuclear translocation of ERK
following estrogen-independent and estrogen-dependent
stimuli
As a ¢rst step toward elucidating the molecular mechanisms
that mediate the nuclear translocation of ERK in response to
ligand-independent stimulation, the intracellular distribution
of a series of mutant ERs was examined. Rad91 cells, treated
as described above, were transfected with wild-type ERK or
the deletion mutant ER-vAB (which lacks the A/B domain
consisting of amino acids 1^180, but contains the known E2-
dependent nuclear localization signal at amino acids 256^263).
Like WT ER, ER-vAB was predominantly extra-nuclear in
SFM and localized to the nucleus following E2 treatment. In
contrast, however, ER-vAB did not localize to the nucleus
following stimulation with ED-FBS, EGF, or S-FBS (Fig.
5A). Additional mutational analyses were then conducted fo-
cusing on residues within the A/B domain previously identi-
¢ed as potential phosphorylation sites. As shown in Fig. 5B,
the single base pair mutant in which alanine is substituted for
serine at amino acid 118 also localized to the nucleus in re-
sponse to E2, but not with ED-FBS or EGF stimulation.
3.4. Estrogen-independent stimuli cause nuclear localization of
ERK by a MAP kinase-dependent pathway
Based on previous studies in non-vascular cells demonstrat-
ing MAP kinase-mediated ligand-independent activation of
ERK via phosphorylation of serine 118 in the A/B domain
of the ER, we next sought to determine whether MAP kinase
mediates ED-FBS-induced nuclear translocation of the ER in
VSMC. Pharmacologic inhibition of MAP kinase with the
MEK1 inhibitor PD98059 completely abolished ED-FBS-in-
duced nuclear translocation of ERK (Fig. 6A). PD98059 also
blocked EGF-induced nuclear translocation (Fig. 6A). In con-
trast, PD98059 had no e¡ect on E2-induced nuclear translo-
cation (Fig. 6A). Inhibition of MAP kinase activation by
overexpression of a dominant negative MAP kinase kinase
(DN-MAPKK) also inhibited ED-FBS-induced and EGF-in-
duced ER translocation, but had no e¡ect on E2-induced
translocation (Fig. 6A). Consistent with the above ¢ndings,
co-transfection of a constitutively activated MAPKK plasmid
enhanced nuclear localization of wild-type ERK even in qui-
escent cells (Fig. 6A). Overexpression of the activated
MAPKK was unable to cause nuclear localization of the
ER-S118A mutant (data not shown).
Based on the ¢ndings presented above, we hypothesized
that substitution of serine 118 of ERK with a charged amino
acid such as glutamate would mimic the e¡ects of MAP ki-
nase-mediated phosphorylation of the ER and result in a mu-
tant ER that would translocate to the nucleus even in the
absence of growth factor stimulation. As hypothesized, ER-
S118E constitutively localized to the nucleus even in SFM
(Fig. 6B). Taken together, these data support a role for
MAP kinase in mediating mitogen-, but not E2-induced ER
nuclear localization.
4. Discussion
ERs mediate both the long-term genomic e¡ects, and the
Fig. 2. Immunoblot detection of ERs in the cell membrane. Nuclear
and cell membrane fractions were isolated from quiescent Rad91
cells and analyzed for the presence of ER by immunoblotting. A:
ER was detected in the cell membranes of Rad91 cells transfected
with ERK, but not control cells transfected with an empty vector.
Furthermore, treatment with the anti-estrogen ICI 182780 (ICI) in-
creased the abundance of membrane ER. B: ER was also detected
in the cell membrane fraction using an antibody directed against the
C-terminus (AER 320) and the N-terminus (AER 314) of the ER.
C: EGF receptor was detected in the cell membrane fractions but
not in the nuclear fractions (data not shown). D: Lack of contami-
nation of the membrane fraction with nuclear proteins is demon-
strated by the absence of the nuclear protein Ku86 in the membrane
fractions, whereas it was readily detected in the nuclear fractions.
One representative example from three independent experiments
with similar results is shown.
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short-term non-genomic e¡ects of estrogen. Though ERs have
classically been thought of as being con¢ned to the nucleus,
previous reports support the existence of membrane-associ-
ated ERs. More recent work con¢rms the existence of mem-
brane-associated ERs, and further suggests that this popula-
tion of ER mediates the non-genomic e¡ects of estrogen
[23,32]. These data demonstrate that cells contain at least
two subpopulations of ERK, nuclear and membrane-associ-
ated, that likely regulate di¡erent cellular processes. To
date, however, little is known regarding the molecular mech-
anisms that regulate the distribution of the ER between nu-
clear and membrane fractions. Furthermore, though rapid
e¡ects of estrogen have also been reported in VSMC, there
are few data examining whether these cells also express mem-
brane-associated ERs. Therefore, in the present study we
sought (1) to determine whether human VSMC can express
membrane ER; and (2) to examine the molecular mechanisms
that regulate the intracellular localization of ER in these cells.
The data presented above demonstrate in quiescent human
VSMC, transient transfection of the full-length, wild-type
ERK results in expression of a subpopulation of ER that is
membrane-associated. This conclusion is supported by immu-
nocytochemical detection of ERK using a variety of antibod-
ies, and by studies using £uorescent-tagged ERK. This con-
clusion is supported further by immunoblot analysis of
membrane fractions demonstrating ER in the membrane frac-
tion and lack of contamination of the membrane fraction with
other nuclear proteins. Additional studies using non-permea-
bilized cells, and cells treated with gentle trypsinization sug-
gest that at least a portion of the membrane ER is exposed to
the exterior of the cell. Given the lack of a putative trans-
membrane domain in the ER, the mechanism by which ERK
localizes to the extracellular space is unclear, and additional
studies are needed to explore this question further.
The data presented above also demonstrate stimulus-specif-
ic regulation of the intracellular localization of the ER. Estro-
gen-dependent and estrogen-independent stimuli capable of
transcriptional activation of ERK both result in nuclear local-
Fig. 3. Physiologic stimuli regulate the intracellular distribution of ERK in human VSMC. Rad91 cells and human saphenous vein derived
VSMC (HSVSMC) were transfected with GFP-ERK and visualized either in the quiescent state or after overnight stimulation with various
agents. A: Quiescent Rad91 cells express extensive extra-nuclear ER. B: Nuclear localization of the ER was induced following estrogen stimu-
lation. C: Estrogen-induced nucleus localization was inhibited by co-incubation with ICI 182780. D^F: Treatment of Rad91 cells with ED-FBS
(D) EGF (E), or S-FBS (F) also induced nuclear localization of the ER. G^I: Similarly, in HSVSMC the ER re-distributed from an extra-nu-
clear pattern in quiescent cells (G) to a nuclear pattern following stimulation with ED-FBS (H) and the nuclear translocation was blocked by
ICI 182780 (I).
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ization of the receptor, but they do so by di¡erent molecular
mechanisms. Mutational analyses demonstrate that a deletion
mutant of the ER lacking the N-terminal A/B domain remains
responsive to estrogen, but not to estrogen-independent stim-
uli. More detailed mutational analyses suggested the hypoth-
esis that mitogen-induced activation of MAP kinase mediates
hormone-independent nuclear localization of the ER, as ER
mutants lacking the MAP kinase phosphorylation consensus
site no longer become nuclear-localized following ED-FBS or
EGF stimulation. These mutants did however remain estrogen
responsive, underscoring the distinct molecular pathways that
mediate estrogen-dependent and estrogen-independent e¡ects.
A role for MAP kinase in regulating ER nuclear localization
is supported further by experiments demonstrating that inhi-
bition of MAP kinase activation, either by pharmacologic or
genetic means, inhibits mitogen-induced ER nuclear localiza-
tion, and that constitutive activation of MAP kinase leads to
nuclear localization of the ER even in quiescent cells. The
mechanism by which ICI blocks nuclear translocation of the
ER in response to hormone-independent stimulation is un-
clear. It is compatible with our previous demonstration that
ligand-independent ER activation is blocked by ICI, but not
by tamoxifen, presumably because ICI blocks activation of
both AF-1 and AF-2, whereas the e¡ects of tamoxifen are
limited primarily to AF-2 alone. The role of signaling path-
ways such as receptor tyrosine kinase-mediated cascades in
regulating the intracellular localization of ERK is unknown,
but worthy of additional investigation.
Several limitations of the current study deserve mention.
First, the majority of these studies were conducted in transi-
ently transfected cells expressing high levels of ERK. Thus, it
remains to be seen whether endogenously expressed ER in
VSMC also localizes to the cell membrane, and if so, whether
similar molecular mechanisms regulate its intracellular local-
ization. We undertook a series of preliminary experiments to
address these issues in untransfected VSMC but were unable
to convincingly demonstrate membrane ER. This likely results
from the very low abundance of total ERK in these cells at
baseline [36,39], making detection of a membrane fraction
technically di⁄cult. Endogenously expressed membrane ERK
Fig. 4. Summary data demonstrating re-distribution of the ER in
human VSMC in response to physiologic stimuli. A: Cells with ex-
clusively nuclear staining are shown. B: The distribution of cyto-
plasmic staining is shown. Bars represent means þ S.E.M.; n = 6 in-
dependent experiments. P6 0.01 for all treatments vs. SFM.
Fig. 5. ER mutants demonstrate that distinct molecular pathways
mediate E2-dependent and E2-independent nuclear localization of
the ER in human VSMC. A: ER-vAB, an N-terminal truncation
that lacks the AF-1 transcription activation domain, transfected into
Rad91 cells translocates to the nucleus in response to estrogen (E2)
treatment, but not in response to stimulation with either ED-FBS
or EGF. B: Similarly, ER-S118A, an alanine for serine substitution
at amino acid 118, transfected into Rad91 cells also translocates to
the nucleus in response to estrogen (E2) treatment, but not in re-
sponse to stimulation with either ED-FBS or EGF. Bars represent
means þ S.E.M.; n = 6 independent experiments.
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was demonstrated in GH3B6 cells, however, con¢rming pre-
vious observations of endogenous membrane-associated ER
from other laboratories. In addition, all of our studies were
conducted in cultured vascular cells, and thus the presence of
membrane ER and the mechanisms that regulate ER local-
ization in cells in the intact vessel remain to be examined.
Finally, the current investigation did not include examination
of ERL though ERL also likely regulates important physio-
logic processes within vascular cells.
In summary, the data presented above demonstrate that in
immortalized human VSMC: (1) ERK localizes to the cell
membrane in quiescent, unstimulated cells ; (2) both estro-
gen-dependent and estrogen-independent activators induce
nuclear localization of ERK ; (3) distinct molecular mecha-
nisms mediate estrogen-dependent and estrogen-independent
ER nuclear localization; (4) MAP kinase mediates hormone-
independent, but not hormone-dependent nuclear localization
of ERK.
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